{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:46:58Z","timestamp":1759366018321,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010148","name":"Spanish Association of Urology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010148","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.acuro.2020.01.005","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:20:19Z","timestamp":1583713219000},"page":"430-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resultados de la rama espa\u00f1ola del Estudio Randomizado Europeo de Screening del C\u00e1ncer de Pr\u00f3stata (ERSPC). Actualizaci\u00f3n tras 21 a\u00f1os de seguimiento"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"Luj\u00e1n Gal\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"P\u00e1ez Borda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Llanes Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Romero Cajigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Berenguer S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2020.01.005_bib0155","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acuro.2020.01.005_bib0160","unstructured":"Instituto Nacional de Estad\u00edstica. Defunciones seg\u00fan la Causa de Muerte. A\u00f1o 2017. [actualizado 19 Dic 2018; consultado 30 Ago 2018].Disponible en: http:\/\/www.ine.es\/prensa\/edcm_2017.pdf."},{"key":"#cr-split#-10.1016\/j.acuro.2020.01.005_bib0165.1","unstructured":"National Cancer Institute. SEER Cancer Statistics Review 1975-2016. Table 23.10 Cancer of the Prostate (Invasive) Risk of Being Diagnosed With Cancer in 10, 20 and 30 Years, Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age, and Lifetime Risk of Dying from Cancer Given Alive at Current Age Males, 2014-2016 By Race\/Ethnicity. [actualizado 1 Abr 2019"},{"key":"#cr-split#-10.1016\/j.acuro.2020.01.005_bib0165.2","unstructured":"consultado 30 Ago 2019]. Disponible en: https:\/\/seer.cancer.gov\/csr\/1975_2016\/browse_csr.php?sectionSEL=23&pageSEL=sect_23_table.10."},{"key":"10.1016\/j.acuro.2020.01.005_bib0170","first-page":"175","article-title":"Quantifying the role of PSA screening in the US prostate cancer mortality decline","volume":"19","author":"Etzioni","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.acuro.2020.01.005_bib0175","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.eururo.2019.03.010","article-title":"Could differences in treatment between trial arms explain the reduction in prostate cancer mortality in the European Randomized Study of Screening for Prostate Cancer?","volume":"75","author":"Carlsson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2020.01.005_bib0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2020.01.005_bib0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2018.0154","article-title":"Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial","volume":"319","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.acuro.2020.01.005_bib0190","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/bju.14580","article-title":"Extended follow-up for prostate cancer incidence and mortality among participants in the prostate, lung colorectal and ovarian randomized cancer screening trial","volume":"123","author":"Pinsky","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2020.01.005_bib0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.acuro.2015.02.003","article-title":"Actualizaci\u00f3n de los resultados de la rama espa\u00f1ola del Estudio aleatorizado europeo de screening del c\u00e1ncer de pr\u00f3stata (ERSPC)","volume":"39","author":"Lujan","year":"2015","journal-title":"Actas Urol Esp"},{"issue":"Supp l2","key":"10.1016\/j.acuro.2020.01.005_bib0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1465-5101.2003.04393.x","article-title":"The Spanish contribution to the European Randomized Study of Screening for Prostate Cancer","volume":"92","author":"Berenguer","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2020.01.005_bib0205","unstructured":"ERSPC Study, Committee Structure. [actualizado 3 Oct 2014; consultado 31 Ago 2019]. Disponible en: http:\/\/www.erspc.org\/members\/committees\/.."},{"key":"10.1016\/j.acuro.2020.01.005_bib0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2006.07.012","article-title":"Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trial","volume":"51","author":"Aus","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2020.01.005_bib0215","unstructured":"European Comission. Eurostat. Causes of death - deaths by country of residence and occurrence. [actualizado 16 Ago 2019; consultado 31 Ago 2019]. Disponible en: https:\/\/appsso.eurostat.ec.europa.eu\/nui\/submitViewTableAction.do."},{"key":"10.1016\/j.acuro.2020.01.005_bib0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/pcan.2014.7","article-title":"Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC)","volume":"17","author":"Lujan","year":"2014","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 3","key":"10.1016\/j.acuro.2020.01.005_bib0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1157\/13101089","article-title":"Accuracy of cancer death certificates in Spain: a summary of available information","volume":"20","author":"Perez-Gomez","year":"2006","journal-title":"Gac Sanit"},{"key":"10.1016\/j.acuro.2020.01.005_bib0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.acuro.2015.10.005","article-title":"Contaminaci\u00f3n de ant\u00edgeno espec\u00edfico-prost\u00e1tico a largo plazo en la rama espa\u00f1ola del Estudio Aleatorizado Europeo de Screening del C\u00e1ncer de Pr\u00f3stata (ERSPC)","volume":"40","author":"Lujan","year":"2016","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2020.01.005_bib0235","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa1201637","article-title":"Quality-of-life effects of prostate-specific antigen screening","volume":"367","author":"Heijnsdijk","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2020.01.005_bib0240","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schroder","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.acuro.2020.01.005_bib0245","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2008.02.013","article-title":"Cancer screening: evidence and practice in Europe 2008","volume":"44","author":"Hakama","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acuro.2020.01.005_bib0250","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(09)70066-X","article-title":"Trials of prostate-cancer screening are not worthwhile","volume":"10","author":"Dubben","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuro.2020.01.005_bib0255","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.medcli.2018.08.001","article-title":"Cribado del c\u00e1ncer de pr\u00f3stata con ant\u00edgeno espec\u00edfico prost\u00e1tico en varones mayores de 75 a\u00f1os","volume":"152","author":"Lujan","year":"2019","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.acuro.2020.01.005_bib0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"Screening for prostate cancer: U.S Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acuro.2020.01.005_bib0265","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.acuro.2020.01.005_bib0270","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2019.04.033","article-title":"Structured population-based prostate-specific antigen screening for prostate cancer: The European Association of Urology Position in 2019","volume":"76","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2020.01.005_bib0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA Guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2020.01.005_bib0280","unstructured":"American Urological Association (AUA). Early Detection of Prostate Cancer (2018). [actualizado 2018; consultado 6 Dic 2019]. Disponible en: https:\/\/www.auanet.org\/guidelines\/prostate-cancer-early-detection-guideline"},{"key":"10.1016\/j.acuro.2020.01.005_bib0285","first-page":"70","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acuro.2020.01.005_bib0290","unstructured":"American Cancer Society (ACS). American Cancer Society Recommendations for Prostate Cancer Early Detection. [actualizado 1 Ago 2019; consultado 6 Dic 2019]. Disponible en: https:\/\/www.cancer.org\/cancer\/prostate-cancer\/detection-diagnosis-staging\/acs-recommendations.html."},{"key":"10.1016\/j.acuro.2020.01.005_bib0295","unstructured":"National Comprehensive Cancer Network (NCCN). Prostate Cancer Early Detection. [actualizado 31 May 2019; consultado 6 Dic 2019]. Disponible en: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate_detection.pdf."},{"key":"10.1016\/j.acuro.2020.01.005_bib0300","unstructured":"Ministerio de Sanidad y Pol\u00edtica Social. Estrategia en C\u00e1ncer del Sistema Nacional de Salud. [actualizado 22 Oct 2009; consultado 6 Dic 2019]. Disponible en: https:\/\/www.mscbs.gob.es\/organizacion\/sns\/planCalidadSNS\/pdf\/ActualizacionEstrategiaCancer.pdf."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480620300188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480620300188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:36:34Z","timestamp":1759322194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480620300188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0210480620300188"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2020.01.005","relation":{},"ISSN":["0210-4806"],"issn-type":[{"type":"print","value":"0210-4806"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resultados de la rama espa\u00f1ola del Estudio Randomizado Europeo de Screening del C\u00e1ncer de Pr\u00f3stata (ERSPC). Actualizaci\u00f3n tras 21 a\u00f1os de seguimiento","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2020.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}